Max Higgins, Senior Consultant, Author at EverGlade

Max Higgins, Senior Consultant

Max Higgins, Senior Consultant
BARDA RRPV RAPID Solicitation Rapid Antibody Production

BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production

Leave a Comment / All Posts, BARDA, Life Sciences / By

RRPV-26-10-RAPID The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Project Proposals (RPP) to stand up U.S.-based rapid antibody and protein binder production platforms that can go from pathogen gene sequence to immunoassay-ready reagents within weeks instead of months. This is a targeted opportunity to position platform […]

BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production Read More »

DARPA Hemorrhage Countermeasures RFI

DARPA Hemorrhage Countermeasures RFI

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-SN-26-61 Overview of Solicitation Hemorrhage remains one of the leading causes of preventable death on the battlefield, with existing countermeasures often falling short in their transition from laboratory research to clinical and commercial application. In response, the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) has released a Request for Information (RFI) under

DARPA Hemorrhage Countermeasures RFI Read More »

ARPA-H STOMP Program

ARPA-H STOMP Program: Advancing the Science of Microplastics and Human Health

Leave a Comment / ARPA-H, Life Sciences / By

STOMP_ISO_ARPA-H-SOL-26-152 The Advanced Research Projects Agency for Health (ARPA-H) has released an Innovative Solutions Opening (ISO) for the Systematic Targeting of Microplastics (STOMP) program, signaling a major federal investment in understanding and addressing the health impacts of micro- and nano-plastics (MNPs). As mounting evidence links MNP exposure to a range of adverse health outcomes, ARPA-H

ARPA-H STOMP Program: Advancing the Science of Microplastics and Human Health Read More »

DARPA Eris

DARPA’s ERIS Initiative Opens a New Pathway for Breakthrough Defense Innovation

Leave a Comment / DARPA, Emerging Technologies / By

DARPA_ERIS_Announcement-_R9_1_April_2026 A New Front Door for Disruptive Defense Technology The Defense Advanced Research Projects Agency (DARPA), in partnership with its marketplace manager, the Applied Research Institute (ARI), has launched the Expedited Research Innovation System (ERIS), a long-term open call intended to accelerate the discovery and acquisition of novel technologies relevant to U.S. national security. DARPA

DARPA’s ERIS Initiative Opens a New Pathway for Breakthrough Defense Innovation Read More »

MCDC Host-Directed Therapeutics Initiative

MCDC’s Host-Directed Therapeutics Initiative

Leave a Comment / All Posts / By

The Medical Chemical, Biological, Radiological, and Nuclear Defense Consortium (MCDC), managed by Advanced Technology International (ATI), has issued a Request for Information (RFI) focused on “Host-Directed Medical Countermeasures.” This effort, led in support of the Capability Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND), represents an early step toward shaping a

MCDC’s Host-Directed Therapeutics Initiative Read More »

MCDC Prophylaxis Military Protection

MCDC Seeks Industry Input on Prophylaxis in Advanced Development for Military Biological Threat Protection

Leave a Comment / All Posts / By

The Medical CBRN Defense Consortium (MCDC), through Advanced Technology International (ATI), has issued a Request for Information (RFI) on behalf of the Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) for “Prophylaxis in Advanced Development.” This notice is intended strictly for information gathering and planning and does not constitute a Request

MCDC Seeks Industry Input on Prophylaxis in Advanced Development for Military Biological Threat Protection Read More »

Genesis Mission Everglade Insight

Strategic Deep Dive into the Genesis Mission and What It Means for Government Contractors

Leave a Comment / All Posts / By

The White House’s Genesis Mission, first announced in 2025, represents a foundational shift in how the federal government approaches science, engineering, and advanced technology systems at scale. While the initial announcement positioned the mission as a national call to action, its real significance has become clearer over time. Genesis is less a standalone initiative and

Strategic Deep Dive into the Genesis Mission and What It Means for Government Contractors Read More »

ARPA-H 1-CURE Initiative

ARPA-H’s 1-CURE Initiative to Revolutionize Universal Cancer Radiotherapy

Leave a Comment / ARPA-H, Life Sciences / By

1-CURE_ISO_ARPA-H-SOL-26-147 Cancer remains one of the leading causes of death globally, with existing treatment modalities often limited by cost, accessibility, and effectiveness, particularly for metastatic disease. In response, the Advanced Research Projects Agency for Health (ARPA-H) has released an Innovative Solutions Opening (ISO) under solicitation ARPA-H-SOL-26-147 for the One Comprehensive Universal Radiotherapy for Everyone (1-CURE)

ARPA-H’s 1-CURE Initiative to Revolutionize Universal Cancer Radiotherapy Read More »

ARPA-H Delphi Program Draft Featured Image

ARPA-H’s Delphi Program Draft ISO Signals New Opportunities in Continuous Biosensing

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA-H-SOL-26-153+DRAFT+Delphi+ISO Overview of the DELPHI Program The Advanced Research Projects Agency for Health (ARPA-H) has released a Draft Innovative Solutions Opening (ISO) for the Delphi program through its Resilient Systems Office (RSO). The draft announcement, ARPA-H-SOL-26-153, is intended to inform the research community about an upcoming funding opportunity and allow potential performers time to prepare

ARPA-H’s Delphi Program Draft ISO Signals New Opportunities in Continuous Biosensing Read More »

DARPA’s O-CIRCUIT Special Notice

DARPA’s O-CIRCUIT Special Notice Signals a New Frontier in Low-Power Biological Computing

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-SN-26-58-Amendment-01 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued Special Notice DARPA-SN-26-48 to alert the research community to a forthcoming program titled Organoid Cytomorphic Intelligence Resulting from Convergent Understanding and Information Transfer (O-CIRCUIT). This notice gives early visibility into a program that aims to explore an unconventional but

DARPA’s O-CIRCUIT Special Notice Signals a New Frontier in Low-Power Biological Computing Read More »

DARPA’s Virtual-Integrated Twin

DARPA’s Virtual-Integrated Twin for Autonomous Lifesaving

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-26-26 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has officially released Program Solicitation DARPA-PS-26-26 for the Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) program. This formal solicitation builds on the previously issued Special Notice and establishes the full scope, structure, and submission process for the program. DARPA’s overarching goal for

DARPA’s Virtual-Integrated Twin for Autonomous Lifesaving Read More »

DARPA BORDEAUX Program

DARPA’s BORDEAUX Program to Advance Cyber Security Performance in Artificial Intelligence

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-26-20 The Defense Advanced Research Projects Agency (DARPA), through its Information Innovation Office (I2O), has released Program Solicitation DARPA-PS-26-20 for the BORDEAUX program. DARPA, the Department of Defense’s (DoD) premier research and development agency, is charged with making pivotal early technology investments that create technological surprise for national security. With BORDEAUX, DARPA is soliciting innovative

DARPA’s BORDEAUX Program to Advance Cyber Security Performance in Artificial Intelligence Read More »

Scroll to Top